ALT
USDAltimmune Inc. Common Stock
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$3.920
Máximo
$4.160
Mínimo
$3.775
Volumen
2.59M
Fundamentos de la Empresa
Capitalización de Mercado
428.8M
Industria
Biotecnología
País
United States
Estadísticas de Negociación
Volumen Promedio
2.84M
Bolsa
NGM
Moneda
USD
Rango de 52 Semanas
Noticias Relacionadas
Altimmune Announces Early Completion of Enrollment in RECLAIM Phase 2 Trial Evaluating Pemvidutide in Alcohol Use Disorder
Enrollment completed ahead of schedule, underscoring strong interest from patient community in a potential new therapeutic option On track to complete the 24-week treatment period and announce topline results in 2026
Metsera the US obesity biotech at centre of Novo, Pfizer bidding war
Metsera has become the obesity drug market's hottest ticket.
Altimmune to Report Third Quarter 2025 Financial Results and Provide Business Update on November 6, 2025
GAITHERSBURG, Md., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (NASDAQ:ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases,
Acciones Relacionadas
LIFWW
MSP Recovery Inc. Warrant
FRPT
Freshpet Inc.
ALGN
Align Technology
ATLC
Atlanticus Holdings Corporation
GLQ
Clough Global Equity Fund Clough Global Equity Fund Common Shares of Beneficial Interest
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.